Current track



Malaria drug trial against Covid-19 agreed

Written by on April 20, 2020

Pharma company Novartis has reached a deal with the US to go ahead with a trial of the malaria drug hydroxychloroquine against Covid-19 in 440 hospitalised patients, the Swiss drugmaker says.

The drug has been used to treat malaria for decades and has been promoted by US President Donald Trump after some anecdotal evidence suggested it might help against coronavirus.

But there is no scientific proof that it actually helps.

“We recognise the importance of answering the scientific question of whether hydroxychloroquine will be beneficial for patients with Covid-19 disease,” the company said.

Labs around the globe are rushing to develop a cure or a vaccine against the new coronavirus.


Reader's opinions

Leave a Reply

Your email address will not be published. Required fields are marked *

× Chat with us on WhatsApp